SubscribeElsewhere on HealthThreads: Adenocarcinoma | Ovarian cancer | Melanoma | Endometrial cancer | Thyroid cancer | Lung cancer |
Critical Marker Of Response To Gemcitabine In Pancreatic Cancer Identified By Jefferson Researchers 
Medical News Today | Sat, Jun 6
Medical News Today is the #7 News Source for Pancreatic cancer
A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University. The protein, called Hu antigen R (HuR), is a stress res...
Try These Related Topics
More Medical News Today
Epeius Biotechnologies' Rexin-G Receives FDA Fast Track Designation For The Treatment Of Pancreatic Cancer
Newly Developed Quality Indicators Reveal Variability In Pancreatic Cancer Care
Research Team Formally Develops Quality Indicators To Assess Pancreatic Cancer Treatment
The Lives Of Pancreatic Cancer Patients Prolonged By New Drug Candidate
Related News
Intrinsic chemoresistance to gemcitabine is associated with constitutive and ... - 7thSpace Interactive
ASH: Some Cancer Patients Get VTE Benefit from LMWH
Pretargeted Radioimmunotherapy of Pancreatic Cancer Xenografts: TF10– 90 Y-IMP ... - Journal of Nuclear Medicine
AACR: Emerging Pancreatic Cancer Treatments Evaluated Cancer conference shows ...
New Drug Blocks "Undruggable" Target in Cancer Cells - National Cancer Institute
Interview with Access Pharma CEO: Updates and Outlook
Top Bloggers
| 1 | Booman Tribune |
| 2 | Market Wire |
| 3 | Simple Thoughts - J... |
| 4 | Drudge Retort |
| 5 | Feministe |
| 6 | Woo Factor |
| 7 | 7thspace.com |
| 8 | Wizbang |
| 9 | fivecentnickel.com |
| 10 | NCI Cancer Bulletin |
| 11 | cancer.about.com |
| 12 | Science |
| 13 | MetaFilter |
| 14 | EmpowHer |
| 15 | ajho.com |
Photo Gallery
Mentor Capital Cancer Vaccine Investing Update - Seeking Alpha
Mentor Capital Cancer Vaccine Investing Update Seeking Alpha (blog) IND Filings for ICT‐121 are expected for brain tumors in during 1Q10 while IND Filings for ICT‐121 for pancreatic cancer are expected during 3Q10. ... and more »
Wed, Dec 23 | from seekingalpha.com
